Vaccines
Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route Of Administration, End-user, Geography, Company Analysis - Global Forecast To 2032
The global influenza vaccines market is projected to reach US$ 12.16 Billion by 2032, from US$ 7.60 Billion in 2024. The quadrivalent vaccines dominated the global influenza vaccines market in 2024, and is expected to grow at the fastest rate over the forecast period. Geographically, North America is the largest market for influenza vaccines capturing over 50% share in 2024, owing to rising awareness of influenza viruses, high healthcare expenditure, and increasing research and development activities.
Global Influenza Vaccines Market, Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Promising Influenza Vaccines In Clinical Development, Size, Share, Trends, Major Deals And Recent Developments - Forecast To 2030
The global influenza vaccines market is projected to reach US$ 10.9 Billion by 2030. The vast population base together with significantly low vaccination coverage in emerging markets, the introduction of new vaccines, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will drive the influenza vaccines market.

Global Influenza Vaccines Market, Persons Vaccinated, Impact Of COVID-19, Company Analysis, Size, Share, Growth, Trends, Major Deals - Forecast To 2027
The global influenza vaccines market is projected to exceed US$ 9.5 Billion mark by 2027. Because of the on-going COVID-19 pandemic, getting a flu vaccine will be more important than ever. Flu vaccines will not prevent COVID-19, but they will reduce the burden of flu illnesses, hospitalizations and deaths on the health care system and conserve scarce medical resources for the care of people with COVID-19.

Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast To 2024
The global influenza vaccines market is anticipated to exceed US$ 5.8 Billion mark by 2024, and is presenting ample opportunities to the industry’s players. Influenza viruses are considered as a major cause of morbidity and mortality worldwide.

Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis And Forecast To 2022
Geographically, North America is the largest market for influenza vaccines capturing nearly 50% market share in 2016. Asia is the second largest market for influenza vaccines. Europe is the third largest market for influenza vaccines, followed by Latin America with around XX% share in 2016. Australasia accounted for least share of the influenza vaccines market in 2016.

Europe Influenza Vaccines Market, Persons Vaccinated, Brand Analysis And Forecast To 2021
The European influenza vaccines market is anticipated to reach nearly US$ 650 Million by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide.

Asia And Australasia Influenza Vaccines Market, Persons Vaccinated, Brand Analysis And Forecast To 2021
The Asia and Australasia influenza vaccines market is anticipated to reach nearly US$ 1.5 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide.

Americas Influenza Vaccines Market, Persons Vaccinated, Brand Analysis And Forecast To 2021
The influenza vaccines market in Americas is anticipated to reach nearly US$ 3 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide.

Global Influenza Vaccines Market And Forecast To 2021 - Size, Share, Growth And Trends Analysis
The global influenza vaccines market is anticipated to reach nearly US$ 5 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide.

Global Adult Vaccines Market, Company Analysis And Forecast To 2021
The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 6% over the next five years. Adults are as likely as children to die from diseases that they can be immunized. For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related complications in the elderly.

Pediatric Vaccines Market, Company Sales And Forecast - Global Analysis
Pediatric vaccines are used in the prevention of numerous diseases, such as Hepatitis- A and -B. Measles, Influenza, Polio, Tetanus, and Diphtheria. Increasing government and non-government funding for development of vaccine is the major driver for the pediatric vaccine market.

Influenza Vaccines Market And Forecast - Global Analysis
The influenza vaccine is one of the most lucrative segment of the global vaccines market. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide.

Global Cancer Vaccines Market And Pipeline Vaccines Analysis To 2020
Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. Cancer vaccines can be broadly classified into two segments: prophylactic and therapeutic vaccines. Prophylactic vaccines are used for the prevention of cancer, whereas therapeutic vaccines are used for treatment of cancer.

Global - Adult Vaccines Market And Company Analysis To 2020
The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 7% over the next five years. The driving factors for adult vaccines growth are an increasing acceptance of adult vaccines and the public health focus on flu prevention, as well as introductions of new vaccines.